Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3X1I

hPPARgamma Ligand binding domain in complex with 6-oxo-tetracosahexaenoic acid

3X1I の概要
エントリーDOI10.2210/pdb3x1i/pdb
関連するPDBエントリー3X1H
分子名称Peroxisome proliferator-activated receptor gamma, (8E,12Z,15Z,18Z,21Z)-6-oxotetracosa-8,12,15,18,21-pentaenoic acid (3 entities in total)
機能のキーワードnuclear receptor, transcription regulation, ligand binding domain, diabetes mellitus, zinc-finger, dna-binding, transcription, obesity
由来する生物種Homo sapiens (human)
細胞内の位置Nucleus: P37231
タンパク質・核酸の鎖数2
化学式量合計63644.12
構造登録者
Egawa, D.,Itoh, T.,Yamamoto, K. (登録日: 2014-11-18, 公開日: 2015-04-08, 最終更新日: 2024-10-16)
主引用文献Egawa, D.,Itoh, T.,Yamamoto, K.
Characterization of covalent bond formation between PPAR gamma and oxo-fatty acids.
Bioconjug.Chem., 26:690-698, 2015
Cited by
PubMed Abstract: Covalent modification of proteins is important for normal cellular regulation. Here, we report on the covalent modification of peroxisome proliferator-activated receptor γ (PPARγ), an important drug target, by oxo-fatty acids. In this study, ESI mass spectroscopy showed that the reactivities of oxo-fatty acids with PPARγ are different from one another and that these behaviors are related to the structure of the fatty acids. X-ray crystallography showed that three oxo-fatty acids all bound to the same residue of PPARγ (Cys285), but displayed different hydrogen bonding modes. Moreover, fatty acids formed covalent bonds with both PPARγ moieties in the homodimer, one in an active conformation and the other in an alternative conformation. These two conformations may explain why covalently bound fatty acids show partial rather than full agonist activity.
PubMed: 25785518
DOI: 10.1021/acs.bioconjchem.5b00021
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.4 Å)
構造検証レポート
Validation report summary of 3x1i
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon